Eli Lilly to sell low blood sugar drug to Amphastar for around $1 billion

United States News News

Eli Lilly to sell low blood sugar drug to Amphastar for around $1 billion
United States Latest News,United States Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 36 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 97%

Amphastar Pharmaceuticals will buy Baqsimi from Eli Lilly and Co in a deal worth up to $1.08 billion as it aims to boost its portfolio of low blood sugar drugs, the two companies said on Monday.

in a deal worth up to $1.08 billion as it aims to boost its portfolio of low blood sugar drugs, the two companies said on Monday.

Amphastar will pay $500 million at closing and another $125 million in cash after one year under the deal. Eli Lilly is also eligible to receive milestone payments of up to $450 million based on sales of Baqsimi, the only nasally administered drug to treat severely low blood sugar, or hypoglycemia, in people with diabetes.

Severe hypoglycemia is characterized by altered mental or physical functioning, which if untreated, can lead to loss of consciousness, seizure, coma and even death.Lilly had acquired Baqsimi from Locemia Solutions in 2015. The drug has an active compound glucagon, a form of a hormone produced in the pancreas that stimulates glucose production.The company had received the U.S.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Eli Lilly to sell hypoglycemia treatment for up to $1.1 billion in cash and milestone payments to AmphastarEli Lilly to sell hypoglycemia treatment for up to $1.1 billion in cash and milestone payments to AmphastarShares of Eli Lilly & Co. gained 0.5% in premarket trading Monday, after the drugmaker announced an agreement to sell its hypoglycemia treatment for people...
Read more »

Coca-Cola stock rises on forecast-beating results; Bed Bath & Beyond shares slump and other stocks on the moveCoca-Cola stock rises on forecast-beating results; Bed Bath & Beyond shares slump and other stocks on the moveCoca-Cola, Bed Bath & Beyond, Foghorn Therapeutics and Eli Lilly are among the biggest moving stocks on Monday.
Read more »

A guide to iconic filming locations in 'Blood In Blood Out'A guide to iconic filming locations in 'Blood In Blood Out'30 years after its release, part of what has drawn so many people to “Blood In Blood Out” is the film’s authenticity. Here, take a look at some of the film’s most iconic filming locations across Los Angeles.
Read more »

Sugar House Park closed to vehicles; officials estimate increased water levels as high as 4 feetSugar House Park closed to vehicles; officials estimate increased water levels as high as 4 feetControlled reservoir releases will result in high water at Sugar House Park, and the area will close to vehicle traffic for about a week, officials said Friday.
Read more »

Sugar House Park to be closed to vehicles starting Saturday due to flooding concernsSugar House Park to be closed to vehicles starting Saturday due to flooding concernsSugar House Park is going to be closed off to cars starting this weekend as part of flood control preparation.
Read more »



Render Time: 2025-02-23 03:11:45